No definition available.
Endometroid carcinoma of ovary, excluding all cancers (controls excluding all cancers)
C3_OVARY_ENDOMETROID_EXALLC
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleonly females |
293373 |
2. Check conditionsNone |
293373 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
314 |
4. Check minimum number of eventsNone |
314 |
5. Include endpointsNone |
314 |
6. Filter based on genotype QC (FinnGen only) |
314 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Endometroid carcinoma of ovary, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Endometroid carcinoma of ovary
- Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)
- malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 314 | 314 | - |
| Unadjusted period prevalence (%) | 0.11 | 0.11 | - |
| Median age at first event (years) | 58.92 | 58.92 | - |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 284
- Matched controls
- 2840
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C56.73
ICD-10 Finland
Endomeroid epithelial carcinoma of the ovary
+∞
323.0
246
*
8380/3-C56.9
ICD-O-3
Endometrioid adenocarcinoma, NOS, of ovary
+∞
217.7
180
*
128
Kela drug reimbursment
Cancers of female genital organs
+∞
171.9
147
*
H02AB02
ATC
dexamethasone; systemic
283.3
142.5
135
9
LAF16
NOMESCO Finland
Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer
+∞
135.6
119
*
A03FA01
ATC
metoclopramide; systemic, rectal
19.2
100.5
183
245
C56.71
ICD-10 Finland
Serous epithelial malignant tumor of the ovary
+∞
95.3
86
*
A04AA01
ATC
ondansetron; systemic, rectal
58.3
91.9
107
29
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
85.9
78
*
D39.10
ICD-10 Finland
Tumor of uncertain or unknown nature in the ovary without histology
42.3
81.7
102
37
JAL30
NOMESCO Finland
Omentectomy
145.6
81.1
83
8
C56
ICD-10 Finland
Malignant neoplasm of ovary
+∞
75.4
69
*
C56.00
ICD-10 Finland
Malignant tumor of the ovary without histology
+∞
74.3
68
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
50.8
72.0
86
24
JEA00
NOMESCO Finland
Appendectomy
21.4
64.0
98
68
JN4BD
NOMESCO Finland
Extensive body CT
21.8
59.5
90
59
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
18.6
55.4
89
68
B01AB10
ATC
tinzaparin; parenteral
21.7
54.4
82
52
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
27.9
54.2
75
36
L03AA13
ATC
pegfilgrastim; parenteral
+∞
45.0
42
*
LX1XE
NOMESCO Finland
Other gynecological ultrasound examination
21.8
43.7
65
38
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
42.8
40
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
40.6
38
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
446.0
40.1
39
*
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
+∞
38.4
36
*
A04AA02
ATC
granisetron; systemic, transdermal
218.4
37.8
38
*
LAF10
NOMESCO Finland
Bilateral salpingo-oophorectomy
12.0
35.1
67
71
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
34.0
32
*
A04AA03
ATC
tropisetron; systemic
+∞
34.0
32
*
TPH07
NOMESCO Finland
Cathetrisation of artery
9.5
33.2
73
100
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
33.0
31
*
C56.98
ICD-10 Finland
Malignant tumor of the ovary, indeterminate histology
+∞
33.0
31
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
30.8
29
*
L03AA02
ATC
filgrastim; parenteral
+∞
30.8
29
*
L02BG04
ATC
letrozole; oral
74.3
29.6
33
5
TLE20
NOMESCO Finland
Transvaginal puncture of cul-de-sac
323.3
29.3
29
*
JN4AD
NOMESCO Finland
Body CT examination
14.6
28.1
48
39
B01AB05
ATC
enoxaparin; parenteral
4.2
27.3
145
567
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
19.8
27.1
41
24
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
26.5
25
*
1830A
ICD-9 Finland
Malignant neoplasm of ovary and other uterine adnexa, Ovary
+∞
26.5
25
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
4.3
25.9
126
447
8380/3-C54.1
ICD-O-3
Endometrioid adenocarcinoma, NOS, of endometrium
+∞
25.4
24
*
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
3.8
24.4
149
638
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
24.3
23
*
C56.79
ICD-10 Finland
Other epithelial carcinoma of the ovary
+∞
24.3
23
*
PJD53
NOMESCO Finland
Block dissection of aortic lymph nodes
+∞
23.2
22
*
JAL00
NOMESCO Finland
Biopsy of peritoneum
91.1
23.1
25
*
Z51.5
ICD-10 Finland
Palliative care
18.0
22.6
35
22
JAH00
NOMESCO Finland
Laparotomy
20.6
22.3
33
18
A04AA55
ATC
palonosetron, combinations; systemic
+∞
22.2
21
*
130
Kela drug reimbursment
Malignant tumour
+∞
22.2
21
*
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
4.8
22.0
84
230
JAL20
NOMESCO Finland
Excision or destruction of lesion of peritoneum
124.7
21.9
23
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
21.1
20
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
5.8
20.9
64
136
LCD00
NOMESCO Finland
Hysterectomy
6.3
20.2
57
109
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
+∞
20.0
19
*
WX402
NOMESCO Finland
General anaesthesia
4.8
20.0
73
189
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
14.8
19.8
33
25
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
19.0
18
*
PJD63
NOMESCO Finland
Laparoscopic dissection of aortic lymph nodes
+∞
19.0
18
*
R18
ICD-10 Finland
Ascites
32.6
18.7
24
8
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
+∞
17.9
17
*
C56.72
ICD-10 Finland
Mucinous epithelial carcinoma of the ovary
+∞
17.9
17
*
115
Kela drug reimbursment
Breast cancer
+∞
17.9
17
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
101.5
17.8
19
*
HA1AA
NOMESCO Finland
X-ray mammography
8.3
17.7
40
55
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
4.5
17.1
66
179
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
+∞
16.8
16
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
16.8
16
*
L02BA01
ATC
tamoxifen; oral
180.1
16.7
17
*
L02AB02
ATC
medroxyprogesterone; systemic (progestogens)
63.8
15.9
18
*
WW500
NOMESCO Finland
Blood transfusion
23.7
15.8
22
10
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
15.8
15
*
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
90.2
15.7
17
*
JAL31
NOMESCO Finland
Laparoscopic omentectomy
47.8
15.2
18
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
84.6
14.7
16
*
8461/3-C56.9
ICD-O-3
High grade serous carcinoma of ovary
+∞
14.7
14
*
WC115
NOMESCO Finland
Cytostatic therapy of local tumor recidive with multiple drugs
+∞
14.7
14
*
D39.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Female genital organ, unspecified
+∞
14.7
14
*
XX3DW
NOMESCO Finland
Time consuming IT work
7.8
14.3
33
47
ZX120
NOMESCO Finland
Intravenous
5.4
14.1
44
94
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
9.6
13.8
28
32
WC125
NOMESCO Finland
Demanding cytostatic therapy of local tumor recidive
+∞
13.6
13
*
C567
ICD-10 Finland
NA
+∞
13.6
13
*
JAP00
NOMESCO Finland
Freeing of adhesions in the peritoneal cavity
20.3
13.1
19
10
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
3.6
12.8
62
203
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
12.6
12
*
Z31.5
ICD-10 Finland
Genetic counselling
7.2
12.1
29
44
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.0
12.1
78
315
JAH01
NOMESCO Finland
Laparoscopy
6.7
11.9
30
49
Z80.3
ICD-10 Finland
Family history of malignant neoplasm of breast
31.5
11.8
15
5
N02AA05
ATC
oxycodone; systemic
3.5
11.7
58
193
8441/3-C56.9
ICD-O-3
Serous carcinoma, NOS, of ovary
+∞
11.5
11
*
WC105
NOMESCO Finland
Simple cytostatic therapy of local tumor recidive
+∞
11.5
11
*
X77
ICPC
Malignant neopl genital female other
124.9
11.5
12
*
D39.19
ICD-10 Finland
Tumor of uncertain or unknown nature in the ovary with unspecified histology
21.1
11.3
16
8
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
45.2
11.0
13
*
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
16.3
11.0
17
11
ZXC40
NOMESCO Finland
Use of ultrasound
22.5
10.8
15
7
C56.74
ICD-10 Finland
Mesonephroid epithelial carcinoma of the ovary
+∞
10.5
10
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
10.5
10
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
10.5
10
*
A79
ICPC
Malignancy NOS
+∞
10.5
10
*
LAF11
NOMESCO Finland
Laparoscopic bilateral salpingo-oophorectomy
4.7
10.3
35
82
JFB46
NOMESCO Finland
Resection of sigmoid colon
24.4
10.3
14
6
N80.1
ICD-10 Finland
Endometriosis of ovary
7.6
9.7
22
31
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
15.7
9.6
15
10
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
18.3
9.5
14
8
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
18.3
9.5
14
8
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
9.2
9.4
19
22
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
9.4
9
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
9.4
9
*
L01CB01
ATC
etoposide; systemic
+∞
9.4
9
*
L01BC06
ATC
capecitabine; oral
+∞
9.4
9
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
9.4
9
*
JN2DG
NOMESCO Finland
Very extensive MRI examination of lower part of abdoment with high intensity magnet
51.6
8.7
10
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
92.7
8.5
9
*
HAC20
NOMESCO Finland
Total mastectomy
92.7
8.5
9
*
PJD43
NOMESCO Finland
Excision of aortic lymph nodes
+∞
8.4
8
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
8.4
8
*
8440/3-C56.9
ICD-O-3
Cystadenocarcinoma, NOS, of ovary
+∞
8.4
8
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
8.4
8
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.4
8.2
80
399
JN4CD
NOMESCO Finland
Very extensive body CT
12.2
8.2
14
12
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
34.4
8.1
10
*
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
5.1
8.0
24
50
LC2DE
NOMESCO Finland
Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods
4.6
7.8
26
61
TPX10
NOMESCO Finland
Implantation of vascular injection port
12.3
7.7
13
11
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
25.8
7.6
10
*
PJD44
NOMESCO Finland
Excision of iliac lymph nodes
82.2
7.5
8
*
JAW96
NOMESCO Finland
Other operation on abdominal wall, peritoneum, mesentery or omentum
82.2
7.5
8
*
K56.7
ICD-10 Finland
Ileus, unspecified
9.8
7.4
14
15
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
7.3
7
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
7.3
7
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
7.3
7
*
JFF10
NOMESCO Finland
Loop enterostomy
+∞
7.3
7
*
L02BG03
ATC
anastrozole; oral
+∞
7.3
7
*
18301
ICD-8 Finland
Malignant neoplasm of ovary, Fallopian tube and broad ligament, Ovary
+∞
7.3
7
*
WX306
NOMESCO Finland
Lumbar epidural anesthesy
4.2
7.2
26
66
JAP01
NOMESCO Finland
Laparoscopic freeing of adhesions in the peritoneal cavity
8.6
6.9
14
17
R2110
NOMESCO Finland
Giving the first information
3.2
6.9
35
119
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
41.1
6.8
8
*
JAL01
NOMESCO Finland
Laparoscopic biopsy of peritoneum
41.1
6.8
8
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
5.7
6.7
18
33
B01AB04
ATC
dalteparin; parenteral
4.1
6.7
25
66
8205
FHL
Subradical ovarian malignancy removal (includes possible genital and omet removal)
71.4
6.5
7
*
TJA10
NOMESCO Finland
Laparocentesis
71.4
6.5
7
*
KBV10
NOMESCO Finland
Removal of stent from ureter
71.4
6.5
7
*
XX1AT
NOMESCO Finland
Other puncture with ultrasound guidance
14.7
6.4
10
7
121
Kela drug reimbursment
Severe hypofunction of sexual glands
6.2
6.4
16
27
LCA06
NOMESCO Finland
Biopsy of endometrium
2.5
6.4
54
247
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.7
6.4
44
182
D39.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Uterus
18.5
6.3
9
5
WF002
NOMESCO Finland
Radical radiotherapy
+∞
6.3
6
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
6.3
6
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
6.3
6
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
6.3
6
*
JAQ00
NOMESCO Finland
Extensive excision of peritoneum
+∞
6.3
6
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
+∞
6.3
6
*
Z85.4
ICD-10 Finland
Personal history of malignant neoplasm of genital organs
+∞
6.3
6
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
6.3
6
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
6.3
6
*
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
4.5
6.3
21
50
D39.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Ovary
27.3
6.3
8
*
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
7.0
6.1
14
21
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
201
146
36.48
241.91
12.2
1.5
44.4
23.9
u/ml
1.07
195
141
102
74
19.93
116.45
1.9
1.4
214.0
59.1
pmol/l
4.05
97
74
116
147
11.93
92.13
3.3
1.5
4.1
2.6
ug/l
0.70
91
113
89
275
4.12
25.90
9.3
5.2
0.9
1.7
mmol/l
0.99
75
218
130
546
3.36
23.48
2.3
1.9
—
—
—
0
0
200
1098
3.26
22.64
5.2
3.5
34.0
35.7
g/l
3.75
193
1010
200
1124
3.15
21.24
4.2
3.4
—
—
—
0
0
17
11
16.28
19.49
1.0
1.4
—
—
—
0
0
210
1280
2.93
18.05
9.4
3.3
10.2
10.5
umol/l
0.07
201
1189
35
68
5.67
17.66
3.0
1.9
36.5
102.3
u/ml
0.34
27
59
215
1400
2.70
15.01
17.4
6.2
3.5
4.2
e9/l
5.39
186
1214
47
137
3.86
14.37
13.7
5.9
0.8
0.7
%
0.30
47
137
47
139
3.80
14.07
13.3
5.9
1.4
1.4
%
0.05
47
139
16
23
7.28
10.67
1.0
2.0
3.6
163.6
u/ml
0.48
16
23
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
24
59
4.32
9.16
4.0
2.7
0.4
0.4
u/ml
—
10
41
233
2719
0.45
8.32
4.4
4.7
4.9
4.8
mmol/l
0.41
213
2485
176
1237
1.96
7.83
7.6
4.4
1.2
1.2
mmol/l
8.42
169
1091
242
2775
0.44
7.81
4.9
5.3
2.8
2.8
mmol/l
0.14
219
2525
233
2699
0.47
7.32
4.2
4.6
1.6
1.6
mmol/l
0.71
209
2459
41
166
2.69
7.19
5.4
4.6
7.4
9.9
mmol/l
1.98
41
152
248
2001
2.14
7.05
10.3
5.1
81.6
75.4
u/l
2.35
233
1827
237
2723
0.47
7.03
4.6
4.8
5.9
5.9
mmol/l
0.16
215
2464
182
1357
1.81
6.14
7.9
5.0
1.2
1.2
mmol/l
9.07
169
1156
228
2627
0.52
5.92
5.0
5.4
1.8
2.4
mu/l
0.65
208
2402
222
2577
0.53
5.85
5.6
6.0
39.9
39.9
mmol/mol
0.01
198
2378
94
583
1.87
5.72
1.9
1.6
1.6
1.0
mg/l
1.95
79
456
183
1398
1.74
5.39
4.9
4.0
0.0
0.0
estimate
0.50
24
240
181
1387
1.72
5.19
7.1
5.4
0.0
0.0
estimate
0.00
23
232
50
260
2.10
4.99
2.4
2.0
4.2
5.2
umol/l
1.90
44
220
37
174
2.28
4.73
1.4
1.5
—
—
—
0
0
125
896
1.66
4.40
3.5
3.2
—
—
—
0
0
195
2295
0.60
4.33
4.2
4.4
14.8
14.9
pmol/l
0.18
173
2096
44
230
2.06
4.33
3.4
3.0
2.8
2.5
mmol/l
0.15
34
189
230
2590
0.58
4.11
3.8
4.1
1.3
1.3
mmol/l
0.58
202
2330
188
1515
1.60
3.96
7.2
3.9
6.8
6.7
mmol/l
0.43
181
1401
25
108
2.43
3.87
2.3
3.5
25.1
25.1
mmol/l
0.01
19
97
66
430
1.68
3.24
2.6
2.6
1.7
1.7
e6/l
0.00
32
237
97
696
1.57
3.23
2.9
3.1
0.4
0.5
e6/l
0.42
69
534
7
11
6.48
3.20
1.4
1.0
238.3
320.0
u/l
—
7
11
81
564
1.59
3.05
1.3
1.3
—
—
—
0
0
277
2933
0.53
3.03
36.8
18.6
4.2
4.4
e12/l
12.03
268
2831
26
128
2.12
3.01
13.0
4.9
24.6
25.8
mmol/l
1.05
26
128
123
942
1.50
3.00
5.0
2.1
2.4
2.4
mmol/l
0.23
112
781
18
380
0.44
2.98
3.8
4.8
28.0
34.0
%
—
9
236
10
30
3.41
2.93
1.0
1.3
—
—
—
0
0
15
60
2.58
2.74
2.9
3.0
—
—
—
0
0
7
14
5.09
2.74
1.3
1.5
—
—
—
0
0
9
25
3.67
2.59
1.3
1.2
—
—
—
0
0
40
242
1.75
2.56
1.7
2.1
27.1
35.2
u/l
0.83
32
193
108
834
1.45
2.44
2.8
2.1
57.8
56.9
u/l
0.05
99
750
26
140
1.93
2.40
1.7
1.5
—
—
—
0
0
8
22
3.70
2.38
1.4
1.2
—
—
—
0
0
42
632
0.61
2.30
1.2
1.3
0.6
2.4
u/ml
—
8
166
101
1270
0.70
2.29
2.4
2.3
82.9
80.6
nmol/l
0.29
90
1108
56
382
1.57
2.28
2.6
2.9
3.3
4.9
e6/l
0.70
24
188
66
892
0.67
2.19
2.0
2.0
99.8
142.2
u/l
1.02
58
841
24
132
1.89
2.10
4.0
2.0
1.3
1.2
%
0.31
24
132
9
31
2.96
2.09
1.3
1.2
—
—
—
0
0
5
10
5.06
2.08
1.4
1.2
—
—
—
0
0
5
10
5.06
2.08
1.4
1.2
—
—
—
0
0
5
11
4.60
1.95
1.4
1.2
—
—
—
0
0
187
2097
0.73
1.93
4.1
4.4
16.5
12.9
mm/h
2.07
167
1915
8
30
2.71
1.73
1.0
1.4
—
—
—
0
0
44
305
1.51
1.68
2.9
2.5
23.1
21.8
%
0.21
39
256
160
1381
1.32
1.68
5.2
4.0
0.0
0.0
estimate
0.00
25
244
37
533
0.65
1.65
1.3
1.3
45.3
12.7
u/ml
0.48
11
189
6
20
3.04
1.59
1.3
1.1
—
—
—
0
0
15
79
1.94
1.52
1.5
1.5
—
—
—
0
0
26
163
1.65
1.52
4.2
2.9
4.4
4.5
pmol/l
0.15
26
139
40
284
1.47
1.38
1.7
1.8
—
—
—
0
0
52
399
1.36
1.19
1.7
1.7
—
—
—
0
0
39
285
1.42
1.18
1.8
1.8
—
—
—
0
0
0
33
0.00
1.17
0.0
1.1
—
—
—
0
0
31
428
0.69
1.13
1.4
1.5
—
—
—
0
0
8
41
1.98
1.09
1.3
1.2
—
—
—
0
0
134
1506
0.81
1.08
2.5
2.7
—
—
—
0
0
275
2848
0.72
1.04
17.6
9.0
23.6
22.6
u/l
0.52
269
2717
11
60
1.86
1.04
1.5
1.5
—
—
—
0
0
9
47
1.94
1.03
1.0
1.4
—
—
—
0
0
9
47
1.94
1.03
1.0
1.4
—
—
—
0
0
104
1192
0.81
0.99
3.1
2.7
114.2
90.3
ug/l
0.66
96
1083
0
30
0.00
0.98
0.0
1.1
—
103.6
—
0
7
7
37
1.91
0.94
1.0
1.2
—
—
—
0
0
65
780
0.79
0.92
1.8
1.6
1.6
1.3
mmol/l
1.17
55
663
30
220
1.40
0.91
2.7
2.0
50.8
64.3
ml/min/173m2
1.57
17
85
17
250
0.66
0.87
3.1
3.2
85.3
77.8
ng/l
0.24
17
217
274
2829
0.75
0.86
29.9
14.3
71.2
71.0
umol/l
0.05
274
2829
108
1218
0.83
0.85
2.2
2.1
82.0
99.4
pmol/l
2.67
50
554
0
24
0.00
0.79
0.0
1.3
—
—
—
0
0
0
24
0.00
0.79
0.0
1.3
—
—
—
0
0
0
24
0.00
0.79
0.0
1.3
—
—
—
0
0
5
98
0.50
0.79
1.2
1.3
—
25.2
—
0
6
6
34
1.78
0.76
1.3
1.1
—
—
—
0
0
63
529
1.24
0.76
4.6
4.2
23.0
112.4
ng/l
2.54
50
417
49
590
0.80
0.72
1.4
1.7
1328.7
1222.3
nmol/l
0.30
37
431
116
1041
1.18
0.71
4.5
3.7
29.7
61.9
ng/l
0.46
87
720
5
27
1.87
0.68
1.0
1.1
—
—
—
0
0
10
62
1.63
0.66
1.3
1.4
—
—
—
0
0
7
44
1.60
0.65
1.3
1.2
—
—
—
0
0
45
540
0.81
0.65
1.2
1.3
18.4
38.8
iu/ml
—
10
173
9
140
0.63
0.62
1.0
1.6
—
—
—
0
0
272
2636
1.24
0.61
20.3
12.3
34.4
20.3
mg/l
7.87
245
2028
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
6
35
1.73
0.58
1.5
1.2
—
—
—
0
0
6
37
1.63
0.56
1.5
1.3
—
—
—
0
0
6
38
1.59
0.54
1.2
1.4
—
—
—
0
0
7
49
1.44
0.46
1.4
1.5
—
—
—
0
0
5
84
0.59
0.46
1.0
1.8
—
—
—
0
0
16
208
0.76
0.45
1.3
1.2
140.3
141.1
iu/ml
—
9
91
44
378
1.19
0.45
12.8
6.8
—
—
—
0
0
7
51
1.38
0.44
1.0
1.1
—
—
—
0
0
5
31
1.62
0.43
1.2
1.2
—
—
—
0
0
65
724
0.87
0.42
1.7
1.5
24.4
22.2
nmol/l
0.55
57
604
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
0
16
0.00
0.41
0.0
1.6
—
26.8
—
0
5
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
0
17
0.00
0.41
0.0
1.8
—
—
—
0
0
0
17
0.00
0.41
0.0
1.8
—
—
—
0
0
0
18
0.00
0.40
0.0
1.9
—
58.1
—
0
13
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
18
144
1.27
0.36
1.3
1.7
—
—
—
0
0
57
631
0.88
0.34
1.5
1.7
1266.1
12072905.7
pmol/l
0.50
41
497
229
2354
0.90
0.33
28.3
14.2
36.3
39.0
%
4.79
162
1558
29
248
1.19
0.33
2.5
3.4
—
—
—
0
0
113
1061
1.10
0.33
5.2
4.2
—
—
—
0
0
7
53
1.33
0.31
1.0
1.1
—
—
—
0
0
91
848
1.10
0.31
3.3
2.7
1843.4
1180.4
ng/l
0.41
81
702
15
121
1.25
0.29
2.8
3.6
5.3
5.3
kpa
0.15
15
114
79
736
1.10
0.27
5.1
4.4
0.0
0.0
estimate
0.48
23
240
13
104
1.26
0.27
1.5
1.4
—
—
—
0
0
5
75
0.66
0.26
1.2
1.3
—
48.6
—
0
10
60
553
1.11
0.25
3.0
2.2
2.5
2.5
mmol/l
1.08
54
482
16
191
0.83
0.25
2.4
1.8
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
10.3
—
0
13
10
80
1.26
0.20
1.5
1.4
—
—
—
0
0
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
9
115
0.78
0.20
1.0
1.3
—
—
—
0
0
72
678
1.08
0.20
2.2
2.3
3.4
3.1
mg/l
0.26
59
565
8
73
1.10
0.16
1.4
1.4
—
—
—
0
0
6
77
0.77
0.16
1.0
1.2
—
—
—
0
0
276
2788
0.92
0.15
27.6
14.9
3.9
4.0
mmol/l
0.79
270
2698
10
85
1.18
0.12
1.5
1.5
—
—
—
0
0
276
2783
0.93
0.12
28.1
14.8
139.3
139.8
mmol/l
2.58
270
2699
61
636
0.95
0.11
1.9
2.1
8858.7
6782.4
umol/l
0.09
52
534
6
73
0.82
0.07
4.3
1.5
—
1.2
—
0
9
161
1632
0.97
0.07
3.8
2.8
52.7
39.0
u/l
1.64
145
1488
10
111
0.90
0.06
1.3
1.4
—
—
—
0
0
25
238
1.05
0.05
4.7
3.5
112.3
221.1
ng/l
1.15
20
218
15
157
0.95
0.01
1.1
1.7
—
—
—
0
0
252
2512
1.02
0.01
21.2
11.3
76.1
76.7
ml/min/173m2
0.17
220
2005
14
143
0.98
0.00
1.1
1.4
—
—
—
0
0
13
135
0.96
0.00
1.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
2.2
—
—
—
0
0
5
57
0.88
0.00
1.0
1.2
0.7
0.6
nmol/l
—
5
52
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
1.7
—
0
6
0
5
0.00
0.00
0.0
1.0
—
21.7
—
0
5
7
75
0.93
0.00
1.0
1.1
—
16.7
—
0
5
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
111.0
—
0
5
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
5
56
0.89
0.00
1.4
1.8
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
9
99
0.91
0.00
1.1
1.2
—
—
—
0
0
9
99
0.91
0.00
1.1
1.2
—
—
—
0
0
5
51
0.98
0.00
3.2
3.0
27.8
26.2
mmol/l
—
5
46
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
111.8
—
0
6
5
50
1.00
0.00
1.0
1.3
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_OVARY_ENDOMETROID_EXALLC – Endometroid carcinoma of ovary, excluding all cancers (controls excluding all cancers)
GWS hits: 1
This endpoint is excluded (different definition than used in FinnGen).